India Clean Air Connect aims to help unlock barriers to air quality action in India at scale
Our goal is to support greater coordination, & collaboration across people working on air quality from diverse expertise and geographies
Visit the air quality champion map
India Clean Air Connect is a response to air quality convenings hosted by the India Climate Collaborative, Clean Air Fund, ClimateWorks Foundation and Shakti Sustainable Energy Foundation in 2019 and 2020.
India's air pollution is not limited to one city or one source
Solving for India's air pollution crisis means:
1.
Aligning efforts across different disciplines to address multiple sources of pollution
2.
Improving air quality in all 124 non-attainment cities, 73 polluted industrial clusters and more
3.
Amplifying and strengthening existing efforts and networks
124 Non-attainment cities
73 Critically polluted industrial clusters
If your work seeks to improve India’s air quality through communication, advocacy, research, policy change, planning, litigation, community engagement or market-based solutions, join #IndiaCleanAirConnect
Employment type:
Employment type:
RFP for mobile monitoring
Sensing Local
Posted:
2 April 2022
30 April 2022
Deadline:
Opportunity brief
The World Health Organization (WHO) is seeking offers for a company to develop the VigiMobile portal, a mobile application to support national and regional pharmacovigilance and vaccine surveillance processes, especially regarding the COVID-19 immunization process. VigiMobile will be a mobile version of VigiFlow, a management system hosted by the Uppsala Monitoring Centre (UMC), which, in collaboration with WHO and other stakeholders, has been expanded to support reporting and analysis of Adverse events following immunization (AEFI) at subnational level.
Anticipated time:
From:
7 April 2022
To:
30 April 2022
About the publisher / organisation
The World Health Organization (WHO) is seeking offers for a company to develop the VigiMobile portal, a mobile application to support national and regional pharmacovigilance